Moderna says Covid booster shot generates promising immune response against variants found in South Africa, Brazil...
Raises 2021 sales forecast for COVID-19 vaccine to $19.2B...
Moderna says early data shows Covid vaccine is 96% effective in teens
Pfizer, Moderna vaccines 94% effective at preventing hospitalizations in elderly, CDC study shows...
Walmart to Acquire Telehealth Provider MeMD
CVS, Walmart, Rite Aid, other large chains working to integrate behavioral services
Cigna beats the Street with $1.2B in profit for Q1...
UnitedHealth launching post-discharge home program for group MA plans...
R1 RCM To Acquire VisitPay For About $300M In Cash...
HCA shareholders reject two union-backed proposals at annual meeting...
Collective Health Valued at $1.5 Billion After Funding Infusion...
Blue Health Insurers Drop Revenue Rule That Limited Competition...
CVS-Aetna Branded Obamacare Plans Target 8 States For 2022 Launch...
CVS Health earnings top estimates as Covid vaccinations, testing boost drugstore sales...
Ascension's technology business to lay off 651 employees...
Cigna's final bid for $1.8 billion Anthem breakup fee denied...
Digital-Health Startups Are Booming. Their Customers Are Overwhelmed...
Physician enablement company Privia Health pops in public debut with outsized IPO...
Biden’s Special Obamacare Sign-Up Already A Boon To Health Insurers...
The Robot Surgeon Will See You Now...
New York-Presbyterian, Empire BCBS contract dispute thrusts union workers into the crossfire...
CMS proposes pulling requirement for hospitals to post private Medicare Advantage rates...
Inpatient pay rule would give hospitals $2.5 billion boost...
STUDY: Lowering the Medicare age could save employers a lot of money...
UHS posts $209M profit in Q1 after repaying hefty Medicare payment loan...
Accolade plans to acquire virtual primary care provider PlushCare in a $450M stock and cash deal...
You Might Like
CORONAVIRUS
Former FDA head Gottlieb: CDC should consider lifting indoor mask mandates...
More than 70% of Americans at least 65 years old now fully inoculated as U.S. Covid cases, vaccinations fall...
This New Covid Vaccine Could Bring Hope to the Unvaccinated World...
Covid Forces Families to Rethink Nursing Home Care...
Covid Testing Has Turned Into a Financial Windfall for Hospitals and Other Providers...
Medicaid enrollment increased by 5M during pandemic...
Lilly takes variant-busting COVID-19 antibody into the clinic...
Almost 20% of unvaccinated Americans still prefer J&J Covid vaccine after U.S. pause, survey shows...
Walgreens teams up with DoorDash, Uber to roll out same-day delivery...
Walgreens Adds Mobile Vaccine Clinics To Reach Communities Hit Hard By Covid-19...
Moderna to Supply Up to 500 Million Vaccine Doses to Covax...
Covid cases fall sharply in U.S., Gottlieb calls vaccination campaign ‘monumental achievement’...
BioNTech executive predicts Europe will reach herd immunity in next few months...
CVS assisting employers with on-site vaccine clinics through Return Ready platform...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
CMS boosts Medicare payments for COVID-19 antibody therapies...
Moderna CEO expects more Covid variants to emerge in coming months: ‘This virus is not going away’...
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns...
EU regulator reviews reports of rare nerve disorder after AstraZeneca shot...
UPDATE: Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine...
Regeneron's COVID-19 therapy helps boost quarterly profit...
LabCorp inks $150M takeover of Myriad Genetics autoimmune testing unit...
Novo Nordisk lifts guidance after first quarter beats expectations...
Elizabeth Holmes back in court for first time in 15 months, putting Silicon Valley culture under scrutiny...
REUTERS: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories...
Ex-Lilly R&D lead Bilenker launches new cancer biotech with Novartis' oncology R&D head Engelman...
DeSantis signs order ending all local COVID-19 restrictions in Florida...
Novartis biosimilar targets rivals' Eylea eye treatment...
Biotech firm Roivant Sciences to go public via $7.3 billion SPAC deal...
Opioid-Crisis Lawsuit Heads for Rare Trial in West Virginia...
Seeking more than $1 billion from three drug distributors: McKesson, AmerisourceBergen and Cardinal Health...
White House relaxes buprenorphine prescribing requirements to expand access to opioid addiction treatment...
GSK pursuing split as easing of COVID curbs aids earnings...
Pfizer CEO: Oral drug to prevent COVID-19 could be ready next year...
Drug pricing legislation hits a wall amid Democratic disagreements...
You Might Like
